Your browser doesn't support javascript.
loading
A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study.
Fenske, Timothy S; Shah, Namrata M; Kim, Kyung Mann; Saha, Sandeep; Zhang, Chong; Baim, Arielle E; Farnen, John P; Onitilo, Adedayo A; Blank, Jules H; Ahuja, Harish; Wassenaar, Tim; Qamar, Rubina; Mansky, Patrick; Traynor, Anne M; Mattison, Ryan J; Kahl, Brad S.
Afiliação
  • Fenske TS; Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Shah NM; Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Kim KM; Department of Biostatistics and Medical Informatics, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
  • Saha S; Department of Biostatistics and Medical Informatics, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
  • Zhang C; Department of Biostatistics and Medical Informatics, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
  • Baim AE; Division of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Farnen JP; Gundersen Lutheran Health System, La Crosse, Wisconsin.
  • Onitilo AA; Marshfield Clinic, Weston, Wisconsin.
  • Blank JH; St. Vincent Regional Cancer Center, Green Bay, Wisconsin.
  • Ahuja H; Aspirus Regional Cancer Center, Wausau, Wisconsin.
  • Wassenaar T; ProHealth Care Cancer Center, Waukesha, Wisconsin.
  • Qamar R; Aurora Cancer Care, Wauwatosa, Wisconsin.
  • Mansky P; Bellin Health, Green Bay, Wisconsin.
  • Traynor AM; Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
  • Mattison RJ; Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
  • Kahl BS; Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
Cancer ; 121(19): 3465-71, 2015 Oct 01.
Article em En | MEDLINE | ID: mdl-26079295

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Sirolimo / Bortezomib Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Sirolimo / Bortezomib Idioma: En Ano de publicação: 2015 Tipo de documento: Article